Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Animalcare Group PLC | AQSE:ANCR.GB | Aquis Stock Exchange | Ordinary Share | GB0032350695 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 239.00 | 224.00 | 254.00 | 239.00 | 239.00 | 239.00 | 0.00 | 07:07:43 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Nov 2021 to Nov 2024
TIDMANCR
RNS Number : 9200J
Animalcare Group PLC
29 April 2022
ANIMALCARE GROUP PLC
(the "Company" or the "Group")
Grant of options and PDMR Dealing
29 April 2022. Animalcare Group plc (AIM: ANCR), the international animal health business, announces that, on 28 April 2022, nil-cost options over a total of 302,037 ordinary shares with a nominal value of 20p per share ("the Options") were awarded to the Executive Directors and PDMRs of the Company and to members of the Senior Executive Team pursuant to the Company's Long Term Incentive Plan.
The awards will vest on 1 July 2025 following the assessment of performance criteria based on Earnings Per Share (EPS) growth per annum and Total Shareholder Return (TSR) over a three-year financial period ending 30 June 2025 which are as follows:
Hot Features
Premium
Earnings Per Share growth per Extent to which EPS tranche will
annum vest
Less than 3% 0%
-----------------------------------
3% 25%
-----------------------------------
10% 100%
-----------------------------------
Between 3% and 10% Between 25% and 100% on a straight
line basis
-----------------------------------
Rank of the Company's TSR compared Extent to which the TSR tranche will
to the Comparator Group vest
Upper quartile or above 100%
-------------------------------------
Between median and upper quartile Pro rata between 25% and 100% on
a ranking basis
-------------------------------------
Median 25%
-------------------------------------
Below median 0%
-------------------------------------
50% of the option award will be subject to the EPS performance condition and the remaining 50% will be subject to the TSR performance condition. Accordingly, if one of the performance conditions is met but the other is not, the Option award will only vest as per the above.
After the grant of the Options, the PDMRs set out below hold the following Options and ordinary shares:
PDMR Options Awarded Total Options Ordinary Shares
Jennifer Winter 130,620 580,795 7,000
---------------- -------------- ----------------
Chris Brewster 53,488 240,778 280,513
---------------- -------------- ----------------
Options over a further 117,929 ordinary shares were granted to other members of the Senior Executive Team and Leadership Team.
The notification in respect of the Option Awards set out in the Annex below was made subject to the requirements of Article 19 of the Market Abuse Regulation:
ANNEX
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Jennifer Winter, Chief Executive Officer
----------------------- ----------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status See 1(a) above - Ms Winter is classified as
a PDMR of the Company
----------------------- ----------------------------------------------
b) Initial notification Initial Notification
/Amendment
----------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name Ani
malcare Group plc
----------------------- ----------------------------------------------
b) LEI 213800A7XPQ528RMCC72
----------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------
a) Description of the Options in respect of the Long Term Incentive
financial instrument, Plan ("LTIP") over ordinary shares of 20p
type of instrument each
b) Identification code GB0032350695
------------------------------- ------------------------------------------------
Award of options
c) Nature of the transaction(s)
------------------------------- ------------------------------------------------
d) Price(s) and volume(s) Volume(s):
Nil cost options over 130,620 shares
Price: GBPNil
------------------------------- ------------------------------------------------
e) Aggregated information N/A
* Aggregated volume
* Price
------------------------------- ------------------------------------------------
f) Date of the transaction 28 April 2022
------------------------------- ------------------------------------------------
g) Place of the transaction Outside a trading venue
------------------------------- ------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Chris Brewster, Chief Financial Officer
---------- ------------------------------------------------------
2 Reason for the notification
a) Position/status See 1(a) above - Mr Brewster is classified
as a PDMR of the Company
------------------------------- ------------------------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------------- ------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------------
a) Name Animalcare Group plc
------------------------------- ------------------------------------------------
b) LEI 213800A7XPQ528RMCC72
------------------------------- ------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
---------------------------------------------------------------------------------
a) Description of the Options in respect of the Long Term Incentive
financial instrument, Plan ("LTIP") over ordinary shares of 20p
type of instrument each
------------------------------- ------------------------------------------------
b) Identification code GB0032350695
------------------------------- ------------------------------------------------
Award of options
c) Nature of the transaction(s)
------------------------------- ------------------------------------------------
d) Price(s) and volume(s) Volume(s):
Nil cost options over 53,488 shares Price:
GBPNil
e) Aggregated information N/A
* Aggregated volume
* Price
--------------------------- ---------------------------------------------
f) Date of the transaction 28 April 2022
--------------------------- ---------------------------------------------
g) Place of the transaction Outside a trading venue
--------------------------- ---------------------------------------------
Enquiries:
Animalcare Group plc
Chris Brewster, Chief Financial Officer +44 (0)1904 487 687
and communications@animalcaregroup.com
Company Secretary
Stifel Nicolaus Europe Limited
(Nominated Adviser & Joint Broker) +44 (0)20 7710 7600
Ben Maddison
Nicholas Harland
Nick Adams
Panmure Gordon
(Joint Broker) +44 (0)20 7886 2500
Corporate Finance:
Freddy Crossley/Emma Earl
Corporate Broking:
Rupert Dearden
About Animalcare
Animalcare Group plc is a UK AIM-listed international development-focused veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSEMFDUEESEFL
(END) Dow Jones Newswires
April 29, 2022 09:19 ET (13:19 GMT)
1 Year Animalcare Chart |
1 Month Animalcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
